1,395 research outputs found

    Study on magnetic materials used in power transformer and inductor

    Get PDF
    Author name used in this publication: K. W. E. ChengRefereed conference paper2006-2007 > Academic research: refereed > Refereed conference paperVersion of RecordPublishe

    Using Network Analysis to Understand Knowledge Mobilization in a Community-based Organization

    Get PDF
    Background Knowledge mobilization (KM) has been described as putting research in the hands of research users. Network analysis is an empirical approach that has potential for examining the complex process of knowledge mobilization within community-based organizations (CBOs). Yet, conducting a network analysis in a CBO presents challenges. Purpose The purpose of this paper is to demonstrate the value and feasibility of using network analysis as a method for understanding knowledge mobilization within a CBO by (1) presenting challenges and solutions to conducting a network analysis in a CBO, (2) examining the feasibility of our methodology, and (3) demonstrating the utility of this methodology through an example of a network analysis conducted in a CBO engaging in knowledge mobilization activities. Method The final method used by the partnership team to conduct our network analysis of a CBO is described. Results An example of network analysis results of a CBO engaging in knowledge mobilization is presented. In total, 81 participants completed the network survey. All of the feasibility benchmarks set by the CBO were met. Results of the network analysis are highlighted and discussed as a means of identifying (1) prominent and influential individuals in the knowledge mobilization process and (2) areas for improvement in future knowledge mobilization initiatives. Conclusion Findings demonstrate that network analysis can be feasibly used to provide a rich description of a CBO engaging in knowledge mobilization activities

    Frequency-Reconfigurable Antenna using Metasurface

    Get PDF
    A frequency-reconfigurable antenna designed using metasurface (MS) to operate at around 5 GHz is proposed and studied. The frequency-reconfigurable metasurfaced (FRMS) antenna is composed of a simple circular patch antenna and a circular MS with the same diameter of 40 mm (0.67 λ) and implemented using planar technology. The MS is placed directly atop the patch antenna, making the FRMS antenna very compact and low profile with a thickness of only 3.048 mm (0.05 λ). The MS consists of rectangular-loop unit cells placed periodically in the vertical and horizontal directions. Simulation results show that the operating frequency of the antenna can be tuned by physically rotating the MS around the center with respect to the patch antenna. The MS placed atop the patch antenna behaves like a dielectric substrate and rotating the MS changes the equivalent relative permittivity of the substrate and hence the operating frequency of the FRMS antenna. Measured results show that the antenna has a tuning range from 4.76 to 5.51 GHz, a fractional tuning range of 14.6%, radiation efficiency and a realized peak gain of more than 80% and 5 dBi, respectively, across the tuning range. © 2013 IEEE.published_or_final_versio

    Maintenance techniques for rechargeable battery using pulse charging

    Get PDF
    Author name used in this publication: Cheng K. W. E.Author name used in this publication: Ho Y. L.Refereed conference paper2006-2007 > Academic research: refereed > Refereed conference paperVersion of RecordPublishe

    Improved survival with lymph node sampling in Wilms tumor

    Full text link
    We sought to determine the impact of number of lymph nodes examined on survival for Wilms tumor (WT). Data from the Surveillance, Epidemiology, and End Results and Florida Cancer Data System were queried for patients < 20 years of age with WT. Of 1805 WT patients, 1340 had lymph node (LN) data available following surgery. The mean age for the cohort was 3.3 ± 2.8 y. Most patients were White (78%), and non-Hispanic (78%). A total of 297 patients (22%) had 0 LN sampled, while 697 (52%) had 1–5 LN, 210 (16%) had 6–10 LN, and 136 (10%) had >10 LN. Overall 5-y survival was 91%. By univariate analysis, 5-y survival was significantly lower for patients with 0 LN sampled (87% versus 91% 1–5 LN; 93% 6–10 LN; 95% >10 LN, P = 0.005). Multivariate analysis confirmed a survival advantage for patients having 1–5 LN (HR 0.600, P = 0.016), 6–10 LN (HR 0.521, P = 0.048), and >10 LN (HR 0.403, P = 0.039) compared with patients with 0 LN examined. Failure to biopsy lymph nodes for WT patients not only increases the risk of local recurrence due to understaging and inadequate adjuvant therapy, but is also an independent prognostic indicator of lower survival

    Abdominal cocoon: uncommon cause of intestinal obstruction in peritoneal dialysis patient.

    Get PDF
    published_or_final_versio

    Human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine: Immunogenicity and safety in healthy Chinese women from Hong Kong

    Get PDF
    Objective To assess the immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in Chinese women aged 18 to 35 years enrolled from Hong Kong. Design Double-blind, randomised controlled trial with vaccine and placebo groups. Setting Single-centre study in Hong Kong. Participants Three hundred women enrolled (150 per group) between March 2006 and June 2007. Interventions Subjects received three doses of human papillomavirus-16/18 vaccine or placebo (aluminium hydroxide), administered intramuscularly at 0, 1, and 6 months. Main outcome measures Human papillomavirus-16/18 seroconversion rates and geometric mean titres at month 7 (in human papillomavirus-16/18 recipients); reactogenicity and safety (in all subjects). Results A total of 294 women completed the study (148 in the vaccine group, 146 in placebo group). All initially seronegative subjects in the vaccine group had seroconverted for human papillomavirus-16/18 antibodies by month 7. Anti-human papillomavirus-16 and anti-human papillomavirus-18 antibody geometric mean titres were 10 422 (95% confidence interval, 8730-12 442) EL.U/mL and 4649 (3975-5437) EL.U/mL, respectively. High compliance (99% in both groups) was observed for the three-vaccination course. The frequencies of local injection site reactions were higher in the vaccine than placebo group; pain being the most common symptom in both groups. Regarding solicited symptoms, fatigue and myalgia were the most frequent in both groups. Five serious adverse events (four in vaccine group, one in placebo group) were reported, but all were considered unrelated to the vaccinations. Conclusion The human papillomavirus-16/18 AS04-adjuvanted vaccine was highly immunogenic, safe, and generally well tolerated in Chinese women from Hong Kong.published_or_final_versio

    Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus

    Get PDF
    Public health risks associated to infection by human coronaviruses remain considerable and vaccination is a key option for preventing the resurgence of severe acute respiratory syndrome coronavirus (SARS-CoV). We have previously reported that antibodies elicited by a SARS-CoV vaccine candidate based on recombinant, full-length SARS-CoV Spike-protein trimers, trigger infection of immune cell lines. These observations prompted us to investigate the molecular mechanisms and responses to antibody-mediated infection in human macrophages.published_or_final_versio

    PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma

    Get PDF
    Protein Tyrosine Phosphatase, Receptor Type G (PTPRG) was identified as a candidate tumor suppressor gene in nasopharyngeal carcinoma (NPC). PTPRG induces significant in vivo tumor suppression in NPC. We identified EGFR as a PTPRG potential interacting partner and examined this interaction. Dephosphorylation of EGFR at EGFR-Y1068 and -Y1086 sites inactivated the PI3K/Akt signaling cascade and subsequent down-regulation of downstream pro-angiogenic and -invasive proteins (VEGF, IL6, and IL8) and suppressed tumor cell proliferation, angiogenesis, and invasion. The effect of Akt inhibition in NPC cells was further validated by Akt knockdown experiments in the PTPRG-down-regulated NPC cell lines. Our results suggested that inhibition of Akt in NPC cells induces tumor suppression at both the in vitro and in vivo levels, and also importantly, in vivo metastasis. In conclusion, we confirmed the vital role of PTPRG in inhibiting Akt signaling with the resultant suppression of in vivo tumorigenesis and metastasis.published_or_final_versio

    Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation

    Get PDF
    Limited antiviral compounds are available for the control of influenza, and the emergence of resistant variants would further narrow the options for defense. The H275Y neuraminidase (NA) mutation, which confers resistance to oseltamivir carboxylate, has been identified among the seasonal H1N1 and 2009 pandemic influenza viruses; however, those H275Y resistant variants demonstrated distinct epidemiological outcomes in humans. Specifically, dominance of the H275Y variant over the oseltamivir-sensitive viruses was only reported for a seasonal H1N1 variant during 2008-2009. Here, we systematically analyze the effect of the H275Y NA mutation on viral fitness and transmissibility of A(H1N1)pdm09 and seasonal H1N1 influenza viruses. The NA genes from A(H1N1)pdm09 A/California/04/09 (CA04), seasonal H1N1 A/New Caledonia/20/1999 (NewCal), and A/Brisbane/59/2007 (Brisbane) were individually introduced into the genetic background of CA04. The H275Y mutation led to reduced NA enzyme activity, an increased K(m) for 3'-sialylactose or 6'-sialylactose, and decreased infectivity in mucin-secreting human airway epithelial cells compared to the oseltamivir-sensitive wild-type counterparts. Attenuated pathogenicity in both RG-CA04(NA-H275Y) and RG-CA04 x Brisbane(NA-H275Y) viruses was observed in ferrets compared to RG-CA04 virus, although the transmissibility was minimally affected. In parallel experiments using recombinant Brisbane viruses differing by hemagglutinin and NA, comparable direct contact and respiratory droplet transmissibilities were observed among RG-NewCal(HA,NA), RG-NewCal(HA,NA-H275Y), RG-Brisbane(HA,NA-H275Y), and RG-NewCal(HA) x Brisbane(NA-H275Y) viruses. Our results demonstrate that, despite the H275Y mutation leading to a minor reduction in viral fitness, the transmission potentials of three different antigenic strains carrying this mutation were comparable in the naive ferret model.published_or_final_versio
    corecore